Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Vaccinations01:51

Vaccinations

54.6K
Overview
54.6K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

63
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
63
Vaccines01:21

Vaccines

53
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
53
Vaccine Production01:23

Vaccine Production

75
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
75

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-quality draft genome of the Listeria monocytogenes, one more vaccine strain against livestock listeriosis.

Scientific data·2026
Same author

Application of Long-Read Sequencing for Genotyping, Epigenetic Profiling and Surveillance of <i>Yersinia pestis</i> Isolates from Natural Foci and Disease Outbreaks in Central Asia.

Vector borne and zoonotic diseases (Larchmont, N.Y.)·2026
Same author

Humoral Response in Cattle Vaccinated with the Heterologous Sheeppox Virus Vaccine for Protection Against Lumpy Skin Disease: A Field Study.

Vaccines·2025
Same author

Whole genome sequencing of Yersinia pestis isolates from Central Asian natural plague foci revealed the role of adaptation to different hosts and environmental conditions in shaping specific genotypes.

PLoS neglected tropical diseases·2025
Same author

Complete genome of the Listeria monocytogenes strain AUF, used as a live listeriosis veterinary vaccine.

Scientific data·2024
Same author

Polarization- and Chaos-Game-Based Fingerprinting of Molecular Targets of Listeria Monocytogenes Vaccine and Fully Virulent Strains.

Current issues in molecular biology·2023

Related Experiment Video

Updated: Apr 11, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K

Plague vaccines: current developments and future perspectives.

Valentina A Feodorova1, Vladimir L Motin2

  • 1Saratov Scientific and Research Veterinary Institute of the Russian Academy for Agricultural Sciences, , Saratov 410028, Russian Federation.

Emerging Microbes & Infections
|June 4, 2015
PubMed
Summary

Developing effective plague vaccines against Yersinia pestis remains a challenge. Next-generation vaccines must consider both humoral and cell-mediated immunity, exploring subunit, DNA, and live vector platforms.

Keywords:
PlagueYersinia pestisprotective antigensvaccine

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K

Related Experiment Videos

Last Updated: Apr 11, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.6K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

4.0K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Yersinia pestis causes plague, a devastating disease with no current safe and effective vaccine.
  • Existing vaccine candidates like the F1/V subunit vaccine primarily target humoral immunity, requiring further human efficacy evaluation.
  • Next-generation plague vaccines necessitate the induction of robust cell-mediated immunity.

Purpose of the Study:

  • To review current advancements in plague vaccine development.
  • To analyze various delivery platforms including subunit, DNA, and live vectors.
  • To discuss strategies for controlled attenuation of Yersinia pestis.

Main Methods:

  • Comprehensive literature review of Yersinia pestis vaccine research.
  • Analysis of different vaccine platforms: subunit, DNA, and live bacterial/viral vectors.
  • Examination of attenuation strategies for virulent Yersinia pestis strains.

Main Results:

  • Subunit, DNA, and live vector platforms show promise for plague vaccine development.
  • Controlled attenuation of Yersinia pestis offers a potential strategy for live vaccines.
  • The need for vaccines inducing both humoral and cell-mediated immunity is highlighted.

Conclusions:

  • Diverse vaccine platforms are under investigation for Yersinia pestis.
  • Balancing humoral and cell-mediated immune responses is crucial for effective plague vaccines.
  • Further research is needed to evaluate vaccine efficacy and safety in humans.